Unprecedented quantities of vaccines could be produced by 28 manufacturers in 10 countries over the next two years to tackle the COVID-19 pandemic, the UN children's agency UNICEF said on Thursday, as it announced it would help lead efforts to procure and distribute them.
Brazil's president Jair Bolsonaro, who has consistently downplayed the severity of the coronavirus outbreak, reiterated on Thursday that COVID-19 vaccinations will not be obligatory when they become available.
Mexico is pressing ahead with an effort to forge COVID-19 vaccine alliances across a wide ideological spectrum of countries from France to Cuba, as a World Health Organization (WHO) vaccine initiative will fall short of its needs.
Peru will start testing coronavirus vaccines from China's Sinopharm and US drug maker Johnson & Johnson in September, researchers said, which should help the country gain faster access to inoculations once the vaccines are approved.
United States pharmaceutical company Johnson & Johnson has added Chile, Argentina, and Peru to the Latin nations where it plans to conduct Phase III trials for its vaccine against COVID-19, the company confirmed on Wednesday.
Brazil approved on Tuesday human clinical trials for a potential COVID-19 vaccine developed by Johnson & Johnson, the fourth candidate to trial in the Latin American country that has become key to the global race for a vaccine.
Nations that hoard possible COVID-19 vaccines while excluding others will deepen the pandemic, World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus said on Tuesday, issuing a last-ditch call for countries to join a global vaccine pact.
Mexico will need up to 200 million coronavirus vaccine doses, according to a senior government official, and inoculation of its 120 million inhabitants could start as early as April if clinical trials and regulatory approvals for pharmaceutical firm AstraZeneca go as planned.
The European Union has agreed to buy at least 300 million doses of AstraZeneca's potential COVID-19 vaccine in its first such advance purchase deal, which could weaken plans led by the World Health Organization (WHO) for a global approach.
President Alberto Fernández, announced on Wednesday that Argentina together with Mexico, will produce for Latin America the coronavirus vaccine developed by the AstraZeneca laboratory in collaboration with the British University of Oxford.